JULIPTA - Trademark Details
Status: 605 - Abandoned - After Publication
Image for trademark with serial number 87174410
Serial Number
87174410
Word Mark
JULIPTA
Status
605 - Abandoned - After Publication
Status Date
2020-04-30
Filing Date
2016-09-16
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2017-01-31
Law Office Assigned Location Code
M10
Employee Name
ELLINGER FATHY, JESSIC
Statements
Goods and Services
Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines affecting sensory organs; Pharmaceuticals and medicines affecting the central nervous system; Pharmaceuticals and medicines affecting urogenital organs; Pharmaceuticals and medicines affecting circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure diseases and disorders; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression; Pharmaceuticals, namely, neuroprotective agents; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; Pharmaceutical preparations for skin care used in connection with anti-aging, the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, facial aesthetic surgery, facial aesthetic reconstruction, breast aesthetics; topical antibiotics, anti-inflammatories, anti-infectives, anti-glaucoma eye drops and decongestant formulations; sterile ointments for medical use; ocular wetting solutions, artificial tears and formulations pharmaceutical preparations for the treatment of minor ocular inflammations and allergic conditions; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lighteners; Pharmaceuticals and cosmeceuticals, namely, medicated skin cleansers, toners, moisturizers, skin rejuvenators, rehydrating creams, and lotions for the face and body
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
8 - Abandoned
Class Status Date
2020-04-30
Primary Code
005
Correspondences
Name
SUSAN J. HINCHEY
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2016-09-20NEW APPLICATION ENTERED IN TRAM
2016-09-21NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2016-12-21ASSIGNED TO EXAMINER
2016-12-22APPROVED FOR PUB - PRINCIPAL REGISTER
2017-01-11NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2017-01-31PUBLISHED FOR OPPOSITION
2017-01-31OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2017-02-16TEAS POST PUBLICATION AMENDMENT RECEIVED
2017-03-03ASSIGNED TO PETITION STAFF
2017-03-04CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
2017-03-28NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2017-08-16TEAS EXTENSION RECEIVED
2017-08-16EXTENSION 1 FILED
2017-08-16EXTENSION 1 GRANTED
2017-08-18NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2018-01-30TEAS EXTENSION RECEIVED
2018-01-30EXTENSION 2 FILED
2018-01-30EXTENSION 2 GRANTED
2018-02-01NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2018-09-07TEAS EXTENSION RECEIVED
2018-09-07EXTENSION 3 FILED
2018-09-07EXTENSION 3 GRANTED
2018-09-11NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2019-03-01TEAS EXTENSION RECEIVED
2019-03-01EXTENSION 4 FILED
2019-03-01EXTENSION 4 GRANTED
2019-03-05NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2019-09-20TEAS EXTENSION RECEIVED
2019-09-24CASE ASSIGNED TO INTENT TO USE PARALEGAL
2019-09-20EXTENSION 5 FILED
2019-09-24EXTENSION 5 GRANTED
2019-09-25NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2020-04-29TEAS EXPRESS ABANDONMENT RECEIVED
2020-04-30ABANDONMENT - AFTER PUBLICATION
2020-04-30ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION